← Back to Clinical Trials
Recruiting NCT05024292

Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Ischemic Stroke
Sponsor Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age 95 Years
Start Date 2022-01-01
Completion 2026-12
Interventions
rapid local ischemic postconditioning (RL-IPostC)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To determine the safety and efficacy of in situ ischemic postconditioning immediately after successful reperfusion in AIS patients underwnet EVT.

Eligibility Criteria

Inclusion Criteria: 1. Adult (age ≥ 18 to 95 years) patients with an occlusion of the internal carotid artery or M1 or M2 segment of the middle cerebral artery,; 2. Patients with a score of at least 6 on the National Institutes of Health Stroke Scale (NIHSS) at admission and a score of 0 or 1 on the modified Rankin scale before the onset of stroke; 3. Patients with a score of at least 6 on the Alberta Stroke Program Early CT score (ASPECTS) value; 4. Baseline multimodal-CT imaging, including NCCT, CTA and CTP, performed at the trial-site hospital 5. The modified thrombolysis in cerebral infarction (mTICI) scale 2b to 3 achieved in the infarct-related artery after the last thrombectomy attempt Exclusion Criteria: 1. Stoke of large artery atherosclerotic origin or other determined factors (such as dissection) or tandem occlusion; 2. Patients underwent rescue angioplasty or stenting after thrombectomy

Related Trials

}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology